IGM Biosciences Inc (IGMS)
9.255
-0.20
(-2.06%)
USD |
NASDAQ |
May 02, 14:21
IGM Biosciences Price to Book Value: 2.677 for May 2, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 01, 2024 | 2.734 |
| April 30, 2024 | 2.786 |
| April 29, 2024 | 2.806 |
| April 26, 2024 | 2.719 |
| April 25, 2024 | 2.213 |
| April 24, 2024 | 2.302 |
| April 23, 2024 | 2.227 |
| April 22, 2024 | 1.952 |
| April 19, 2024 | 2.083 |
| April 18, 2024 | 2.143 |
| April 17, 2024 | 2.352 |
| April 16, 2024 | 2.661 |
| April 15, 2024 | 2.722 |
| April 12, 2024 | 2.650 |
| April 11, 2024 | 2.418 |
| April 10, 2024 | 2.366 |
| April 09, 2024 | 2.528 |
| April 08, 2024 | 2.534 |
| April 05, 2024 | 2.534 |
| April 04, 2024 | 2.572 |
| April 03, 2024 | 2.612 |
| April 02, 2024 | 2.644 |
| April 01, 2024 | 2.734 |
| March 28, 2024 | 2.791 |
| March 27, 2024 | 2.681 |
| Date | Value |
|---|---|
| March 26, 2024 | 2.511 |
| March 25, 2024 | 2.519 |
| March 22, 2024 | 2.976 |
| March 21, 2024 | 2.959 |
| March 20, 2024 | 2.852 |
| March 19, 2024 | 2.869 |
| March 18, 2024 | 3.020 |
| March 15, 2024 | 3.078 |
| March 14, 2024 | 2.950 |
| March 13, 2024 | 2.878 |
| March 12, 2024 | 2.878 |
| March 11, 2024 | 3.023 |
| March 08, 2024 | 3.619 |
| March 07, 2024 | 3.509 |
| March 06, 2024 | 3.535 |
| March 05, 2024 | 3.497 |
| March 04, 2024 | 3.543 |
| March 01, 2024 | 3.659 |
| February 29, 2024 | 3.647 |
| February 28, 2024 | 3.953 |
| February 27, 2024 | 4.103 |
| February 26, 2024 | 4.022 |
| February 23, 2024 | 3.736 |
| February 22, 2024 | 3.699 |
| February 21, 2024 | 3.898 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.9062
Minimum
Oct 31 2023
18.77
Maximum
Dec 08 2020
4.846
Average
3.533
Median
Price to Book Value Benchmarks
| Inotiv Inc | 0.4160 |
| Synlogic Inc | 0.5038 |
| BioXcel Therapeutics Inc | -- |
| Xilio Therapeutics Inc | 0.9923 |
| NovaBay Pharmaceuticals Inc | 1.977 |
Price to Book Value Related Metrics
| PS Ratio | 227.12 |
| Price | 9.255 |
| Earnings Yield | -51.65% |
| Market Cap | 544.07M |